Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Rank in Stocks #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Share Price
$4.06
Last synced: 2024-02-23
Market Cap
$145.61M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Theseus Pharmaceuticals, Inc. (THRX)

Category

Stock split history for Theseus Pharmaceuticals, Inc. (THRX)
Theseus Pharmaceuticals, Inc. stock (symbol: THRX) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 26, 2026.
One THRX share bought prior to Aug 26, 2026 would equal to 0 THRX shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH